Test blood markers to predict kidney transplant rejection
Part of Immune system & allergy, Kidney & urinary clinical trials.
This study looks at special blood tests to help predict when kidney transplant rejection might happen. If the markers work, they could help doctors catch rejection earlier and adjust treatment sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult (18 years or older)
- You must be a kidney transplant candidate or already have a kidney transplant
- You cannot be part of a multi-organ transplant
- You cannot take part if you have HIV
- You cannot take part if you have hepatitis C (HCV)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a blood test that looks for tiny pieces of the donor's DNA in your blood to check how your new kidney is doing. It may help doctors monitor your transplant and spot problems early, possibly without needing a biopsy.
This trial is testing a new blood test (called TreaT-Assay) to help diagnose acute rejection after a kidney transplant. The goal is to catch rejection earlier and more accurately, so you can get the right treatment faster.
This trial tests a blood test that may help monitor kidney transplant health by detecting signs of rejection earlier. It aims to see if using this blood test can lead to better long-term outcomes for transplant recipients.
This study looks for pieces of kidney DNA in the blood of people who have a kidney transplant and need a biopsy. The goal is to see if this test can help doctors know if the kidney is being rejected without needing a biopsy.
This study tests a blood test called GraftAssure that may help doctors detect if your body is rejecting your new kidney. By monitoring this, the test could help prevent kidney damage and improve transplant outcomes.
This study looks at kidney transplant patients who are getting a kidney biopsy for usual clinical reasons. It tests whether special blood test results (from a sample taken as part of the study) can help spot transplant kidney problems earlier or more accurately.
Hear when a new Graft Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.